Piper Sandler analyst Ryan Todd lowered the firm’s price target on Delek US (DK) to $17 from $18 and keeps a Neutral rating on the shares. With two months in the books in the First Quarter, the firm is adjusting its Q1 2025 and 2025 estimates for the refiners in-line with margins to date and the increase in 2025 full year margins. While significant market volatility year-to-date doesn’t exactly provide encouragement on the shelf life of Piper’s estimates, at present it sees downside to Q1 estimates, but generally 10%-15% upside for the remainder of 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK:
- Delek US price target lowered to $15 from $16 at TD Cowen
- Delek US price target lowered to $15 from $17 at Wells Fargo
- Delek US Holdings: Sell Rating Due to Missed Cash Flow Expectations and Increased Operating Expenses
- Delek US Reports Q4 2024 Financial Results
- Delek US Reports Record Earnings and Strategic Growth
Questions or Comments about the article? Write to editor@tipranks.com